Tadeusz Hawrot is the founder of the Psychedelic Access and Research European Alliance (PAREA), a Brussels-based initiative working to prepare Europe for the integration of psychedelic-assisted therapies into healthcare systems. In this interview, he reflects on the policy landscape, regulatory challenges, and the future of access to these emerging treatments in the EU.

With the new EU drug strategy now adopted, key questions remain about its direction and implementation—especially the balance between public health, human rights, and security. We spoke with Anna Dovbakh, Chair of the Civil Society Forum on Drugs, about what the strategy means in practice and the role of civil society moving forward.

As Hungary heads toward a pivotal election, the camera turns on two of its most prominent drug policy advocates. In this interview conducted by Arild Knutsen, Drugreporter founders Péter Sárosi and István Gábor Takács reflect on decades of activism—and explain why they are now taking their fight to the streets to challenge an increasingly repressive system.

We spoke with Pavel Bém, a Czech psychiatrist and former mayor of Prague in Vienna during the 69th session of the Commission on Narcotic Drugs (CND) about the country’s latest reforms—from cannabis regulation to psychedelic therapy—and what they mean for the future of drug policy in Europe.

Civil society and drug user activists push harm reduction reforms across the Nordic region – please watch the videos from a side event at the UN Commission on Narcotic Drugs (CND) and learn more about drug policy reform in Scandinavia!

This DUNews video is dedicated to three key topics that today determine the future of Ukrainian drug policy and the healthcare system: the use of psychoactive substances in the treatment of various conditions, the full-fledged legalization of medical cannabis and the introduction of national standards, as well as the revision of Order No. 188 on minimum dosages of psychoactive substances based on European recommendations.

Watch this new video series on how the opioid overdose crisis and Canada’s toxic drug supply impact people in the trades and construction sectors. A guest article by the co-producer of the films, Lorna Thomas, from Moms Stop the Harm.

At the 28th Harm Reduction International Conference, we had the chance to speak with Ethan Nadelmann, founder of the Drug Policy Alliance in the United States, about the present and future of drug policy during Donald Trump’s second term as president. Watch the video here!

Watch Drugreporter’s new video about Coss Marte, a former convict who, thanks to New York State’s Social Equity Program, now runs three cannabis retail shops and a gym where he employs other formerly incarcerated individuals.

This side event at the 68th CND explored the growing body of evidence highlighting the shortcomings of current drug policies to achieve their stated goals of safety, security, public health and ending stigma, while contributing to significant human rights violations. Organised by Norwegian Association for Humane Drug Policy.